HomeCGTX • NASDAQ
add
Cognition Therapeutics Inc
Previous close
$2.37
Day range
$1.30 - $2.05
Year range
$0.90 - $2.95
Market cap
53.28M USD
Avg Volume
341.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 14.10M | 57.16% |
Net income | -9.15M | -48.27% |
Net profit margin | — | — |
Earnings per share | -0.27 | -28.57% |
EBITDA | -14.08M | -57.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 34.67M | -10.66% |
Total assets | 38.85M | -14.92% |
Total liabilities | 9.99M | 1.12% |
Total equity | 28.86M | — |
Shares outstanding | 40.06M | — |
Price to book | 3.29 | — |
Return on assets | -95.27% | — |
Return on capital | -126.80% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -9.15M | -48.27% |
Cash from operations | -7.24M | -167.80% |
Cash from investing | — | — |
Cash from financing | 11.99M | 120,030.00% |
Net change in cash | 4.75M | 272.57% |
Free cash flow | -7.08M | -189.61% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
25